Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix

Abstract

The cellular transcription factor Brn-3a differentially regulates different human papilloma virus (HPV)-16 variants that are associated with different risks of progression to cervical carcinoma in infected humans. The upstream regulatory regions (URRs) of high- and intermediate-risk HPV-16 variants are activated by the cellular transcription factor Brn-3a, whereas the URR of a low-risk HPV-16 variant is not. In this study, we show in transfection assays that Brn-3a and the smoking-related substance nicotine produce stronger responsiveness of the URR of the low- and high-risk variants than with either factor alone, but not the intermediate-risk variant. We determined that this synergistic activity of Brn-3a/nicotine is due to two nucleotide differences in the URR, crucial for oncogenic E6/E7 transactivation. Mutant constructs in which the nucleotide residues were substituted alter Brn-3a/nicotine responsiveness. Importantly, women smokers with high levels of Brn-3a infected with low- or high-risk HPV-16 variants have augmented E6 levels, and were more frequently diagnosed with higher grades of cervical intraepithelial neoplasia (CIN) and cancer, as compared with non-smokers who were infected with similar variants and expressed similar levels of Brn-3a. Therefore, this study defines the specific interplay between the cellular transactivator Brn-3a, the environmental smoking-related substance nicotine and specific HPV variants in cervical carcinogenesis, and thus helps to explain why some women are susceptible to rapid CIN progression and cancer and others are not.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

URR:

upstream regulatory region

CIN:

cervical intraepithelial neoplasia

References

  • Anthony SG, Trung NT, Anna T, Paul WD, Pär S, Juni P et al. (2006). Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev 15: 2141–2142.

    Article  Google Scholar 

  • Bible JM, Mant C, Best JM, Kell B, Starkey WG, Shanti RG et al. (2000). Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. J Gen Virol 81: 1517–1527.

    Article  CAS  Google Scholar 

  • Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J et al. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 85: 796–802.

    Article  Google Scholar 

  • Burghardt E, Girardi F, Lahousen M, Pickel H, Tamussino K . (1991). Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA). Cancer 15: 1037–1045.

    Article  Google Scholar 

  • Cripe TP, Haugen TH, Turk JP, Tabatabai F, Schmid PG, Durst M et al. (1987). Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer and by viral E2 tranactivation and repressor gene products: implication of cervical carcinogenesis. (1987). EMBO J 6: 3745–3753.

    Article  CAS  Google Scholar 

  • Cox MF, Meanwell CA, Maitland NJ, Blackledge G, Scully C, Jordan JA . (1986). Human papilloma virus type-16 homologous DNA in normal ectocervix. Lancet 2: 157–158.

    Article  CAS  Google Scholar 

  • Dasgupta P, Kinkade R, Joshi B, DeCook C, Haura E, Chellappan S et al. (2006a). Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 103: 6332–6337.

    Article  CAS  Google Scholar 

  • Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, Haura E et al. (2006b). Nicotine induces cell proliferation by β-arrestin-mediated activation of Src and Rb–Raf-1 pathways. Clin Invest 116: 2208–2217.

    Article  CAS  Google Scholar 

  • Harkness P, Millar N . (2002). Changes in conformation and subcellular distribution of nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. J Neurosci 22: 10172–10181.

    Article  CAS  Google Scholar 

  • Hellberg D, Nilsson S, Haley NJ, Hoffman D, Wynder E . (1988). Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 15: 910–913.

    Article  Google Scholar 

  • Lane D, Gray EA, Mathur RS, Mathur SP . (2005). Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines. Am J Reprod Immunol 53: 153–158.

    Article  CAS  Google Scholar 

  • Lee SA, Ndisang D, Patel C, Dennis J, Faulkes D, D'Arrigo C et al. (2005). Expression of Brb-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of HSP-27 promoter. Cancer Res 65: 3072–3080.

    Article  CAS  Google Scholar 

  • Lillycrop KA, Budhram-Mahadeo VS, Lakin N, Terrenghi G, Wood JN, Polak JM et al. (1992). A novel POU family transcription factor I closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res 20: 5093–5096.

    Article  CAS  Google Scholar 

  • McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM . (1992). Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1: 125–129.

    CAS  PubMed  Google Scholar 

  • Miller AB . (2001). Natural history of cervical human papillomavirus infections. Lancet 357: 1816–1816.

    Article  CAS  Google Scholar 

  • Morris PJ, Dent CL, Ring CJ, Latchman DS . (1993). The octamer-binding site in the HPV 16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells. Nucleic Acids Res 21: 1019–1023.

    Article  CAS  Google Scholar 

  • Morris PJ, Theil T, Ring CJ, Lillycrop KA, Möröy T, Latchman DS . (1994). The opposite and antagonistic effects of the closely related POU family transcription factors on the activity of a target promoter are dependent upon differences in the POU domain. Mol Cell Biol 14: 6907–6914.

    Article  CAS  Google Scholar 

  • Ndisang D, Budhram-Mahadeo VS, Latchman DS . (1999). Brn-3a transcription factor plays a critical role in regulating human papilloma virus gene expression and determining the growth characteristics of cervical cancer cells. J Biol Chem 274: 28521–28527.

    Article  CAS  Google Scholar 

  • Ndisang D, Budhram-Mahadeo VS, Pedley B, Latchman DS . (2001). The Brn-3a transcription factor plays a key role in regulating the growth of cervical cancer cells in vivo. Oncogene 20: 4899–4903.

    Article  CAS  Google Scholar 

  • Ndisang D, Budhram-Mahadeo VS, Singer A, Latchman DS . (2000). Wide-spread elevated expression of the HPV-activating cellular transcription factor Brn-3a in the cervix of women with CIN3. Clin Sci 98: 601–602.

    Article  CAS  Google Scholar 

  • Ndisang D, Lorenzato F, Sindos M, Singer A, Latchman DS . (2006a). Detection of cervical abnormalities in a developing country using measurement of Brn-3a in cervical smears. Gynecol Oncol 100: 89–94.

    Article  CAS  Google Scholar 

  • Ndisang D, Faulkes DJ, Gascoyne D, Lee SA, Ripley BJ, Sindos M et al. (2006b). Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a. Oncogene 25: 51–60.

    Article  CAS  Google Scholar 

  • Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE . (1997). Identification of tobacco specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 89: 868–873.

    Article  CAS  Google Scholar 

  • Sindos M, Ndisang D, Pisal N, Chow C, Singer A, Latchman DS . (2003a). Measurement of Brn-3a levels in Pap smears provides a novel diagnostic marker for the detection of cervical neoplasia. Gynaecol Oncol 90: 366–371.

    Article  CAS  Google Scholar 

  • Sindos M, Ndisang D, Pisal N, Chow C, Deery A, Singer A et al. (2003b). Latchman D. Detection of cervical neoplasia using measurement of Brn-3a in cervical smears with persistent minor abnormalities. J Gynaecol Cancer 13: 515–517.

    Article  CAS  Google Scholar 

  • Tsai YM, Yang SF, Wu KY, Chuang HY, Wu TN, Ho CK et al. (2007). Lifetime cigarette smoke and second-hand smoke and cervical intraepithelial neoplasm—a community-based control study. Gynaecol Oncol 105: 181–188.

    Article  CAS  Google Scholar 

  • zur Hausen H . (2009). The search for infectious causes of human cancers: where and why. Virology 392: 1–10.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was funded by the Association for International Cancer Research (AICR).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D Ndisang.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ndisang, D., Khan, A., Lorenzato, F. et al. The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix. Oncogene 29, 2701–2711 (2010). https://doi.org/10.1038/onc.2010.33

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.33

Keywords

Search

Quick links